Approval · Notice of Compliance 3821 · 1997
PUREGON: Notice of Compliance 3821
Issued July 2, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3821
- Date
- July 2, 1997
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Human gonadotropin
Products in this notice
Medicinal ingredients
- FOLLITROPIN BETA 75 UNIT per VIAL
- FOLLITROPIN BETA 50 UNIT per AMP
- FOLLITROPIN BETA 100 UNIT per AMP
- FOLLITROPIN BETA 150 UNIT per AMP